Molaxole

Molaxole, the active ingredient in Molaxole, is an osmotic laxative presented as an oral formulation for oral use. It relieves constipation by retaining water in the intestinal lumen, softening stool and facilitating regular bowel movements in adult patients. The formulation complies with EU quality standards and is manufactured under GMP conditions.

GNH USA supplies Molaxole as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, offering reliable sourcing and regulatory‑aligned distribution through a robust logistics network ensuring timely delivery.

Molaxole is an osmotic laxative that acts on the gastrointestinal tract to alleviate constipation. - Functional constipation: softens stool and promotes regular bowel movements. - Opioid‑induced constipation: counteracts opioid‑related reduced intestinal motility. - Chronic idiopathic constipation: provides sustained stool hydration for long‑term management.

Molaxole may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal bloating: feeling of fullness in the abdomen. - Flatulence: increased gas production. - Nausea: mild queasiness. - Mild abdominal cramps: intermittent stomach discomfort. - Diarrhea: loose stools. - Thirst: increased desire to drink fluids.

Serious or Rare Side Effects: - Severe electrolyte imbalance: abnormal sodium or potassium levels. - Severe dehydration: marked loss of body fluids. - Allergic reaction: rash, itching, swelling, or angioedema. - Severe abdominal pain: intense, persistent pain. - Rectal bleeding: blood in stool. - Intestinal obstruction signs: vomiting, inability to pass gas.

When using Molaxole, certain precautions should be observed to ensure safe and effective therapy. - Assess renal function: evaluate kidney health before initiating therapy. - Monitor electrolyte balance: check serum sodium and potassium during treatment. - Use with caution in dehydration: ensure adequate fluid intake. - Avoid in known bowel obstruction: contraindicated if mechanical blockage is present. - Adjust dose in elderly patients: start with the lowest effective amount. - Store at ambient temperature: keep in original packaging, protect from moisture.

Molaxole can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Concurrent osmotic laxatives: may cause excessive fluid loss. - Loop diuretics: increase risk of electrolyte disturbances. - Potassium‑containing supplements: risk of hyperkalemia. - NSAIDs: may exacerbate renal impairment when combined.

Moderate Interactions (Monitor Closely): - Anticholinergic agents: may reduce laxative effectiveness. - Opioid analgesics: may require higher laxative dose. - Antacids: possible alteration of electrolyte composition.